Abstract
For a targeted pharmacologically oriented basic therapy for osteoarthritis, it is important that the drugs should act against the underlying process of cartilage destruction. A deep insight and exact knowledge of the pathogenetic reactions that occur during the course of degenerative joint disease are necessary for the development of such agents. Fortunately, from the field of experimental osteoarthritis research, a large number of new and interesting findings have come to light over the last 5–10 years concerning the pathogenesis of osteoarthritic joint dysfunction. In order to illustrate the present possible starting points for a pharmacological intervention, some aspects of the pathogenesis of osteoarthritis is first briefly described as it is currently understood.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Akatsuka M, Yamamoto Y, Tobetto K, Yasui T, Ando T (1993) In vitro effects of hyaluronan on prostaglandin E2 induction by interleukin-1 in rabbit articular chondrocytes. Agents Action 38: 122–125
Annefeld M, Fassbender HG (1983) Ultrastructural study of the activity of antiarthritic substances. Z Rheumatol 42: 199–202
Armstrong S, Read R, Ghosh P (1994) The effects of intraarticular hyaluronan on cartilage and subchondral bone changes in an ovine model of early osteoarthritis. J Rheumatol 21: 680–688
Bach G (1996) Arthrose-Medikamente mit verzögertem Wirkungseintritt. In: Gräfenstein K (ed) Therapie rheumatischer Erkrankungen. Ecomed, Landsberg/Lech, pp 66–70
Barcelo HA, Wiemeyer JC, Sagasta CL, Macias M, Barreira JC (1987) Effect of S-adenosylmethionine on experimental osteoarthritis in rabbits. Am J Med 83: 55–59
Bassleer C, Reginster JY, Franchimont P (1993) Effects of glucosamine on differentiated human chondrocytes cultivated in clusters. Rev Esp Reumatol 20 [Suppl 11]:Mo95
Dougados M (1996) On behalf of the Group for the Respect of Ethics and Excellence in Science (GREES), osteoarthritis section, Recommendations for the registration of drugs used in the treatment of osteoarthritis. Ann Rheum Dis 55: 552–557
Engfeldt B, Hjertquist S-O (1967) The effect of various fixatives on the preservation of acid glycosaminoglycans in tissues. Pathol Microbiol Scand 171: 219–232
Ghosh P, Holbert C, Read R, Armstrong S (1995) Hyaluronic acid (hyaluronan) in experimental osteoarthritis. J Rheumatol 43 [Suppl]: 155–157
Ghosh P (1994) The role of hyaluronic acid (hyaluronan) in health and disease: interactions with cells, cartilage and components of synovial fluid. Clin Exp Rheum 12: 75–82
Gotoh S, Miyazaki K, Onaya J, Sakamoto T, Tokuyasu K, Namiki O (1988) Experimental knee pain model in rats and analgesic effect of hyaluronate. Nippon Yakurigaku Zasshi 92: 17–27
Gualano M, Berti F, Stramentinoli G (1985) Anti-inflammatory activity of S-adenosylL-methionine in animal models: possible interference with the eicosanoid system. Int J Tissue React 7: 41–46
Harmand MF, Vilamitjana J, Maloche E, Duphil R, Ducassou D (1987) Effects of Sadenosylmethionine on human articular chondrocte differentiation. An in vitro study. Am J Med 83: 48–54
Homandberg GA, Hui F, Wen C, Kuettner KE, Williams JM (1997) Hyaluronic acid suppresses fibronectin fragment mediated cartilage chondrolysis: I. In vitro. Osteoarthritis Cart 5: 309–319
Hübner F, Steinmeyer J, Kalbhen DA (1997) Pharmacological influence on the collagenolytic activities of articular cartilage. Naunyn-Schmiedebergs Arch Pharmacol 355 [Suppl 4]: R87
Ialante A, Di Rosa M (1994) Hyaluronic acid modulates acute and chronic inflammation. Agents Actions 43: 44–47
Ionac M, Parnham MJ, Plauchithiu M, Brune K (1996) Oxaceprol, an atypical inhibitor on inflammation and joint damage. Pharmacol Res 33: 367–373
Jiménez SA, Dodge GR (1997) The effects of glucosamine sulfate (G504) on human chondrocyte gene expression. Osteoarthritis Cart 5 [Suppl A]: 72
Kalbhen DA, Jansen G (1990) Pharmacologic studies on the antidegenerative effect of ademetionine in experimental arthritis in animals. Arzneim-Forsch/Drug Res 40: 1017–1021
Kalbhen DA, Kalkert B (1987) Autoradiography studies of the effect of oxaceprol on the metabolism of joint cartilage in vitro and in vivo. Z Rheumatol 46: 136–142
Kalbhen DA (1987) Pharmakologische Untersuchungen mit chondroprotektiven Substanzen. In: Miehle W (ed) Chondroprotektion: Fakten and Aspekte. pmi Verlag, Frankfurt, pp 18–21
Kikuchi T, Yamada H, Shimmei M (1996) Effect of high molecular weight hyaluronan on cartilage degeneration in a rabbit model of osteoarthritis. Osteoarthritis Cart 4: 99–110
Laurent UB, Fraser JR, Engstrom-Laurent A, Reed RK, Dahl LB, Laurent TC (1992) Catabolism of hyaluronan in the knee joint of the rabbit. Matrix 12: 130–136
Lequesne M (1993) ILAR guidelines for testing slow acting drugs in osteoarthritis (SADOAs). Rev Esp Rumatol 20 [Suppl 11: 220–221
Lequesne MG, Mery C, Samson M, Gerard P (1987) Indexes of severity for osteoarthritis of the hip and knee. Scand J Rheumatol 65 [Supp1]: 85–89
Mankin HJ, Brandt KD (1997) Pathogenesis of osteoarthritis. In: Kelley WN, Ruddy S, Harris ED, Sledge CB (eds) Textbook of rheumatology. WB Saunders, Philadelphia London, pp 1369–1382
Miyazaki K, Goto S, Okawara H (1984) Sodium hyaluronate (SPH): studies on analgesic and anti-inflammatory effects of sodium hyaluronate. Pharmacometrics 28: 1123–1135
Morris EA, Wilcon S, Treadwell BV (1992) Inhibition of interleukin 1 mediated proteoglycan degradation in bovine articular cartilage explants by addition of sodium hyaluronate. Am J Vet Res 53: 1977–1982
Nagase H, Okada Y (1997) Proteinases and matrix degradation. In: Kelley WN, Ruddy S, Harris ED, Sledge CB (eds) Textbook of rheumatology. WB Saunders, Philadelphia London, pp 323–342
Pelletier J-M, Martel-Pelletier J (1993) The pathophysiology of osteoarthritis and the implication of the use of hyaluronan and hylan as therapeutic agents in viscosupplementation. J Rheumatol 20: 19–24
Pelletier JP, Howell DS (1993) Etiopathogenesis of osteoarthritis. In: McCarthy DJ, Koopman WJ (eds) Arthritis and allied conditions. Lea and Febiger, Philadelphia London, pp 1723–1734
Raiss R (1985) Effect of D-glucosamine sulfate on experimentally injured articular cartilage. Comparative morphometry of the ultrastructure of chondrocytes. Fortschr Med 103: 658–662
Riera H, Aprile F, Mitrovic D (1990) Effect of oxaceprol on the proteoglycan and protein synthesis and degradation by cultured calf articular cartilage explants. Rev Rhum 57: 579–583
Sandy JD, Flannery CR, Neame PJ, Lohmander LS (1992) The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglobular domain. J Clin Invest 89: 1512–1516
Setnikar I, Cereda R, Pacini MA, Revel L (1991) Antireactive properties of glucosamine sulfate. Arzneim-Forsch/Drug Res 41: 157–161
Setnikar I, Pacini MA, Revel L (1991) Antiarthritic effects of glucosamine sulfate studied in animal models. Arzneim-Forsch/Drug Res 41: 542–545
Shimazu A, Jikko A, Iwamoto M, Koike T, Yan W, Okada Y, Shinmei M, Nakamura S, Kato Y (1993) Effects of hyaluronic acid on the release of proteoglycan from the cell matrix in rabbit chondrocyte cultures in the presence and absence of cytokines. Arthritis Rheum 36: 247–253
Shimizu C, Yoshioka M, Coutts RD, Harwood FL, Kubo T, Hirasawa Y, Amiel D (1998) Long-term effects of hyaluronan on experimental osteoarthritis in the rabbit knee. Osteoarthritis Cart 6: 1–9
Steinmeyer J, Daufeldt S (1997) Pharmacological influence of antirheumatic drugs on the proteoglycans from interleukin-1 treated articular cartilage. Biochem Pharmacol 53: 1627–1635
Steinmeyer J, Kim C, Sadowski T, Kalbhen DA (1996) Pharmacological influence on the activity of plasmin and plasminogen activators in vitro. Naunyn-Schmiedebergs Arch Pharmacol 353 [Suppl 4]: R7
Stramentinoli G (1987) Pharmacologic aspects of S-adenosylmethionine. Pharmacokinetics and pharmacodynamics. Am J Med 83: 35–42
Tanaka S, Kumano F, Takayama M, Fukuda K (1997) Hyaluronic acid increases proteoglycan synthesis in articular cartilage degraded by interleukin-1. Osteoarthritis Cart 5 [Suppl A]: 66
Vivien D, Galéra P, Loyau G, Pujol J-P (1993) N-acetyl-4-hydroxyproline (Oxaceprol®) and collagen synthesis in cultured synovial cells and articular cartilage. Osteoarthritis Cart 1: 40
Weischer CH (1987) Antinozizeptive und antiinflammatorische Wirkung von S-Adenosylmethionin (SAMe) nach ein-und mehrmaliger intraperitonealer Applikation. In: Bach GL, Miehlke K (eds) Arthrose Workshop über Gumbaral® (Ademetionin). pmi-Verlag, Frankfurt, pp 81–86
Yasui T, Akatsuka M, Tobetto K, Umemoto J, Ando T, Yamashita K, Hayakawa T (1992) Effects of hyaluronan on the production of stromelysin and tissue inhibitor of metalloproteinase-1 (TIMP-1) in bovine articular chondrocytes. Biomed Res 13: 343–348
Yoshioka M, Shimizu C, Harwood FL, Coutts RD, Amiel D (1997) The effect of hyal- uronan during the development of osteoarthritis. Osteoarthritis Cart 5: 257–260
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Steinmeyer, J. (2000). Pharmacological Basis for the Therapy of Osteoarthritis. In: Grifka, J., Ogilvie-Harris, D.J. (eds) Osteoarthritis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-87752-0_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-87752-0_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-87754-4
Online ISBN: 978-3-642-87752-0
eBook Packages: Springer Book Archive